Truist Financial Lowers The Pennant Group (NASDAQ:PNTG) Price Target to $32.00

The Pennant Group (NASDAQ:PNTGFree Report) had its price target decreased by Truist Financial from $38.00 to $32.00 in a report issued on Monday,Benzinga reports. Truist Financial currently has a hold rating on the stock.

A number of other research analysts have also recently commented on PNTG. Royal Bank of Canada increased their price target on The Pennant Group from $26.00 to $38.00 and gave the company an “outperform” rating in a research note on Wednesday, October 23rd. Stephens reissued an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research note on Wednesday, October 9th. Oppenheimer upped their price objective on The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research note on Friday, November 8th. Finally, Wells Fargo & Company started coverage on shares of The Pennant Group in a research report on Thursday, December 19th. They set an “equal weight” rating and a $33.00 target price on the stock. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $36.00.

View Our Latest Stock Report on PNTG

The Pennant Group Price Performance

PNTG stock opened at $26.57 on Monday. The stock has a market cap of $912.63 million, a price-to-earnings ratio of 39.07, a P/E/G ratio of 2.99 and a beta of 1.93. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The company has a 50 day simple moving average of $29.83 and a 200 day simple moving average of $30.58. The Pennant Group has a 1 year low of $14.79 and a 1 year high of $37.13.

Hedge Funds Weigh In On The Pennant Group

A number of hedge funds have recently made changes to their positions in PNTG. Kings Path Partners LLC boosted its holdings in The Pennant Group by 152.9% in the fourth quarter. Kings Path Partners LLC now owns 19,610 shares of the company’s stock valued at $520,000 after acquiring an additional 11,855 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of The Pennant Group by 68.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 205,922 shares of the company’s stock worth $7,351,000 after purchasing an additional 83,664 shares during the period. Principal Financial Group Inc. boosted its stake in shares of The Pennant Group by 14.5% in the 3rd quarter. Principal Financial Group Inc. now owns 12,626 shares of the company’s stock valued at $451,000 after purchasing an additional 1,597 shares during the last quarter. Franklin Resources Inc. increased its position in shares of The Pennant Group by 26.6% during the third quarter. Franklin Resources Inc. now owns 18,347 shares of the company’s stock worth $638,000 after buying an additional 3,859 shares during the period. Finally, Tidal Investments LLC bought a new position in The Pennant Group during the third quarter worth $506,000. 85.88% of the stock is currently owned by institutional investors.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Stories

Analyst Recommendations for The Pennant Group (NASDAQ:PNTG)

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.